Singapore markets closed

Zoetis Inc. (ZTS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
154.51+2.83 (+1.87%)
At close: 4:03PM EDT

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
http://www.zoetis.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees10,600

Key executives

NameTitlePayExercisedYear born
Ms. Kristin C. PeckCEO & Director1.53M2.43M1971
Mr. Glenn C. DavidExec. VP & CFO1.52M1.96M1972
Mr. Juan Ramón AlaixAdvisor & Director3.42M23.37M1951
Dr. Catherine A. KnuppExec. VP and Pres of R&D1.51M3.92M1961
Ms. Roxanne LaganoExec. VP and Chief HR Officer & Global OperationsN/AN/A1965
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate governance

Zoetis Inc.’s ISS governance QualityScore as of 8 December 2019 is 6. The pillar scores are Audit: 1; Board: 2; Shareholder rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.